Catecholaminergic Polymorphic Ventricular Tachycardia Panel Test code: 02213 • 10–21 days turnaround time 7 genes

Catecholaminergic Polymorphic Ventricular Tachycardia Panel

This panel is designed for individuals with a clinical diagnosis or suspected diagnosis of catecholaminergic polymorphic ventricular tachycardia (CPVT). It evaluates genes that are definitively associated with CPVT, as well as genes associated with other inherited cardiac arrhythmia disorders that may present with clinical features similar to CPVT.

Individuals with symptoms or clinical findings suggestive of CPVT may benefit from diagnostic genetic testing. Genetic testing may help:

• Establish or confirm a clinical diagnosis
• Identify an inherited genetic cause of CPVT
• Clarify potential cardiac and arrhythmia risks
• Inform individualized medical management
• Guide appropriate monitoring and risk-reduction strategies
• Support genetic counseling and testing for family members

Family Testing:
Asymptomatic family members of an individual with a known pathogenic variant may also benefit from targeted genetic testing. Identifying family members who carry the familial variant may help guide appropriate clinical evaluation and management and allow them to take precautions, including avoiding certain activities or situations that may trigger symptoms or increase the risk of abnormal heart rhythms.

Genetic testing results may also help identify other relatives who could benefit from clinical evaluation, genetic counseling, and appropriate cardiac risk assessment.